Blog

SynBio: unlocking the commercial potential of a new bioscience industry – European Pharmaceutical Review

SynBio: unlocking the commercial potential of a new bioscience industry
European Pharmaceutical Review
Despite its early stage, the volume of ongoing work to link breakthroughs in basic synthetic biology with promising applications underscores its considerable potential to generate both transformative tools and products. ABPI Head of Manufacturing

2017-08-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.